New York Senate Bill S07641

New York 2025-2026 Regular Session

• Introduced: 4/24/25
• Refer: 4/24/25
• Refer: 1/7/26
• Report Pass: 2/10/26

Caption

Designates all taxes, interest and penalties collected by the opioid excise tax for the New York state drug treatment and public education fund.

Summary

S07641 amends the Tax Law to direct the proceeds of New York’s opioid excise tax into the New York State Drug Treatment and Public Education Fund. Specifically, it requires that all taxes, interest, and penalties collected under the opioid excise tax be paid to that fund, after accounting for any amounts the comptroller reserves for refunds or reimbursements. The bill is framed as a revenue-designation measure rather than a new tax, and it takes effect immediately upon enactment. The practical effect is to earmark opioid excise tax revenue for substance use disorder treatment and public education efforts instead of leaving those receipts to the general disposition rules that would otherwise apply. It amends section 498 of the Tax Law and ties the revenue flow to the fund created in section 99-jj of the State Finance Law, thereby strengthening the dedicated funding stream for opioid-related public health responses. The bill would affect the state’s handling of opioid tax collections and the agencies responsible for administering and distributing those funds. The available voting history suggests the bill was received positively in committee, passing the Senate Budget and Revenue Committee unanimously by a 7-0 vote. There is no recorded committee transcript in the provided materials, so the broader debate is not documented here. The unanimous vote indicates general agreement on the policy goal of using opioid tax revenue for treatment and education. No specific opposition is reflected in the provided record, but the main point of potential contention is the earmarking of tax revenue. Supporters are likely to favor dedicating opioid-related receipts to treatment and prevention, while any concerns would center on whether the full amount should be reserved for the special fund, how refunds and reimbursements are handled, and whether the revenue should instead remain available for broader budgetary uses. The bill’s language suggests a strong preference for targeted public health spending over general fund flexibility.

Impact

This bill would amend Tax Law section 498 to require that opioid excise tax collections, including interest and penalties, be deposited into the New York State Drug Treatment and Public Education Fund, subject to reserves for refunds or reimbursements. It changes the disposition of those revenues and strengthens the statutory link between opioid tax receipts and dedicated treatment/public education spending, affecting state tax administration and the use of collected funds.

Sentiment

The bill appears to have broad support based on the unanimous 7-0 Senate Budget and Revenue Committee vote. With no committee transcript available, there is no detailed record of debate, but the available history suggests a generally favorable view of dedicating opioid tax revenue to treatment and public education.

Contention

The primary policy issue is revenue earmarking: the bill directs all opioid excise tax proceeds to a special fund rather than allowing them to flow through general state revenue processes. Potential concerns could involve the treatment of refunds and reimbursements, the loss of budgetary flexibility, and whether the dedicated fund is the best mechanism for addressing opioid-related harms. No explicit opposition is shown in the provided materials, so any contention is inferred from the structure of the proposal rather than recorded debate.